Stock Movers: Truist Financial Rises, Micron Falls, Novo Nordisk Slides

Truist Financial Stock Performance

• 📈 Truist Financial (TFC) shares saw a 3.4% increase, driven by adjusted EPS and net interest income exceeding expectations.
• 🏦 The bank reported lower-than-expected provisions for credit losses and maintained its full-year pre-tax and pre-provision outlook.
• 🤝 Management confirmed no exposure to bankrupt Tricolor Holdings and some exposure to First Brands, which was accounted for in loan loss provisions.
• 🚗 Regional bank results, despite volatility, highlight strong demand for car loans, partially offsetting concerns about the US consumer.

Micron's China Market Challenges

• 📉 Micron (MU) shares declined by 2% following a Reuters report about halting server chip supplies to Chinese data centers.
• 🚫 This decision stems from the company's failure to recover from a 2023 Chinese government ban, citing security risks to its information infrastructure.
• 🚚 Micron will continue supplying chips to specific Chinese customers like Lenovo for data centers outside China, as well as to the auto and mobile phone sectors.
• 📊 Despite the challenges, an analyst from Mizuho Securities raised Micron's price target to $240 from $195.

Novo Nordisk and Ozempic Price Concerns

• 💊 Novo Nordisk (NOVO B) experienced its largest drop since July, falling 6%, after former President Donald Trump suggested Ozempic prices could be reduced to $150 per month.
• 💰 The US list price for Ozempic is approximately $1,000 monthly, but negotiated prices after insurer discounts are estimated to be 60-70% lower.
• 📉 Other drugmakers, including Eli Lilly, also saw their shares come under pressure due to these discussions.
• ⏳ Novo Nordisk's stock has fallen nearly 60% over the past 12 months.